Resistance To First-Line Antituberculosis Drugs And Prevalence Of pncA Mutations In Clinical Isolates Of Mycobacterium tuberculosis From Zunyi, Guizhou Province Of China

Resistance To First-Line Antituberculosis Drugs And Prevalence Of pncA Mutations In Clinical Isolates Of Mycobacterium tuberculosis From Zunyi, Guizhou Province Of China

Zhimin Cao,1 Yuanbo Lan,1 Ling Chen,1 Min Xiang,1 Zhiyuan Peng,1 Jianyong Zhang,1 Hong Zhang1,2 1Tuberculosis Division, Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563003, People’s Republic of China; 2Department of R...

Full description

Bibliographic Details
Main Authors: Cao Z, Lan Y, Chen L, Xiang M, Peng Z, Zhang J, Zhang H
Format: Article
Language:English
Published: Dove Medical Press 2019-09-01
Series:Infection and Drug Resistance
Subjects:
Mycobacterium tuberculosis
pyrazinamide
drug resistance
pncA mutation
Online Access:https://www.dovepress.com/resistance-to-first-line-antituberculosis-drugs-and-prevalence-of-pnca-peer-reviewed-article-IDR

Internet

https://www.dovepress.com/resistance-to-first-line-antituberculosis-drugs-and-prevalence-of-pnca-peer-reviewed-article-IDR

Similar Items